Schlögl E - Search Results

1

Karyotype and prognosis in non-Hodgkin lymphoma.

Pirc-Danoewinata H, Chott A, Onderka E, Drach J, Schlögl E, Jäger U, Thalhammer F, Nowotny H, Aryee D, Steger GG, et al. Pirc-Danoewinata H, et al. Among authors: schlogl e. Leukemia. 1994 Nov;8(11):1929-39. Leukemia. 1994. PMID: 7967739

2

Phorbol-12,13-dibutyrate improves the quality of cytogenetic preparation in lymphoid malignancies.

Pirc-Danoewinata H, Onderka E, Porenta G, Kundi M, Nowotny H, Schlögl E, Heinz R, Kreiner G, Marosi C. Pirc-Danoewinata H, et al. Among authors: schlogl e. Cancer Genet Cytogenet. 1995 Apr;80(2):129-34. doi: 10.1016/0165-4608(94)00179-f. Cancer Genet Cytogenet. 1995. PMID: 7736430

3

Variability of nm23-H1/NDPK-A expression in human lymphomas and its relation to tumour aggressiveness.

Aryee DN, Simonitsch I, Mosberger I, Kos K, Mann G, Schlögl E, Pötschger U, Gadner H, Radaszkiewicz T, Kovar H. Aryee DN, et al. Among authors: schlogl e. Br J Cancer. 1996 Dec;74(11):1693-8. doi: 10.1038/bjc.1996.616. Br J Cancer. 1996. PMID: 8956779 Free PMC article.

4

Cross-validation of prognostic scores in myelodysplastic syndromes on 386 patients from a single institution confirms importance of cytogenetics.

Pfeilstöcker M, Reisner R, Nösslinger T, Grüner H, Nowotny H, Tüchler H, Schlögl E, Pittermann E, Heinz R. Pfeilstöcker M, et al. Among authors: schlogl e. Br J Haematol. 1999 Aug;106(2):455-63. doi: 10.1046/j.1365-2141.1999.01559.x. Br J Haematol. 1999. PMID: 10460606 Free article.

5

Rare occurrence of Philadelphia chromosome negative (but BCR-ABL positive) CML in a central European population.

Karlic H, Schlögl EE, Nowotny H, Grüner H, Valent A, Auer H, Heinz R. Karlic H, et al. Among authors: schlogl ee. Am J Hematol. 1994 Nov;47(3):253-4. doi: 10.1002/ajh.2830470331. Am J Hematol. 1994. PMID: 7942804 No abstract available.

6

Short-time splenic irradiation for splenomegaly.

Schratter-Sehn AU, Cerveny M, Simmel H, Schlögl E, Schratter A. Schratter-Sehn AU, et al. Among authors: schlogl e. Onkologie. 2003 Feb;26(1):21-4. doi: 10.1159/000069859. Onkologie. 2003. PMID: 12624513

7

Paclitaxel in the salvage treatment of Hodgkin's disease and non-Hodgkin's lymphoma.

Hopfinger G, Heinz R, Pfeilstöcker M, Schlögl E, Waldner R, Pittermann E. Hopfinger G, et al. Among authors: schlogl e. Ann Oncol. 1996 Apr;7(4):423-4. doi: 10.1093/oxfordjournals.annonc.a010613. Ann Oncol. 1996. PMID: 8805938 Free article. Clinical Trial. No abstract available.

8

Minor BCR (m-bcr) rearrangements may appear in major BCR (M-bcr)-positive CML cases.

Karlic H, Grill R, Schlögl E. Karlic H, et al. Among authors: schlogl e. Hematol Pathol. 1992;6(4):203-7. Hematol Pathol. 1992. PMID: 1362728

9

Pre-fibrotic/early primary myelofibrosis vs. WHO-defined essential thrombocythemia: The impact of minor clinical diagnostic criteria on the outcome of the disease.

Jeryczynski G, Thiele J, Gisslinger B, Wölfler A, Schalling M, Gleiß A, Burgstaller S, Buxhofer-Ausch V, Sliwa T, Schlögl E, Geissler K, Krauth MT, Nader A, Vesely M, Simonitsch-Klupp I, Müllauer L, Beham-Schmid C, Gisslinger H. Jeryczynski G, et al. Among authors: schlogl e. Am J Hematol. 2017 Sep;92(9):885-891. doi: 10.1002/ajh.24788. Epub 2017 Jun 9. Am J Hematol. 2017. PMID: 28543356 Free article. Clinical Trial.

10

Granulocyte-macrophage colony-stimulating factor gene in myelodysplastic syndromes.

Karlic HI, Weber E, Schlögl E, Krieger O, Lutz D. Karlic HI, et al. Among authors: schlogl e. Am J Hematol. 1991 Jan;36(1):79-80. doi: 10.1002/ajh.2830360122. Am J Hematol. 1991. PMID: 1984690 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters